Disclaimer: This document is for educational/clinical reference purposes only and does not replace professional medical judgment. Clinicians should consult institutional protocols and the latest peer-reviewed literature for decision-making.

---

Clinical Management of Infective Mononucleosis (IM)

Overview

• Definition: An acute clinical syndrome, most commonly caused by the Epstein-Barr virus (EBV), characterized by the triad of fever, tonsillopharyngitis, and lymphadenopathy.
• Epidemiology: Primarily affects adolescents and young adults (ages 15–24). Seroprevalence exceeds 90% in adults worldwide.
• Classification: Classic IM (EBV-associated); IM-like syndrome (Cytomegalovirus (CMV), Toxoplasma gondii, HIV acute infection, Hepatitis A/B).

Pathophysiology

• Mechanism: EBV infects oropharyngeal epithelial cells and B lymphocytes. The clinical syndrome results from the massive expansion of reactive T lymphocytes (specifically CD8+ cytotoxic cells) attempting to control the infected B cells.
• Risk Factors: Close contact (saliva exchange, "kissing disease"), lack of prior exposure, immunodeficiency.
• Protective Factors: Prior asymptomatic childhood exposure.

Clinical Presentation

Signs and Symptoms

• Cardinal Features: Fever (often high grade), pharyngitis (exudative), and lymphadenopathy (posterior cervical chain).
• Early Signs: Malaise, fatigue, headache, and myalgias (prodrome lasting 1–2 weeks).
• Advanced Signs: Splenomegaly (up to 50–60% of cases), hepatomegaly, palatal petechiae.
• Atypical Presentations: Skin rash (frequently induced by amoxicillin/ampicillin), jaundice, or cough.

Physical Examination

• Inspection: Pharyngeal erythema with white/grey exudates; periorbital edema is a specific but less common sign.
• Palpation: Tender posterior cervical, axillary, and inguinal lymphadenopathy. Abdominal palpation for splenomegaly.

Diagnostic Approach

History Taking

• Key Questions: Duration of illness, presence of odynophagia, inability to tolerate oral intake, history of antibiotic use.
• Red Flags: Respiratory distress (tonsillar hypertrophy), severe left upper quadrant pain (splenic rupture), persistent high fever, or significant weight loss.

Laboratory Tests

• First-Line:
  • CBC with peripheral smear: Shows >50% lymphocytes, with >10% atypical (reactive) lymphocytes.
  • Heterophile antibody test (Monospot): High specificity, but sensitivity is lower in the first week of illness.
• Confirmatory: EBV-specific antibody panel (VCA IgM/IgG, EBNA) if Monospot is negative but clinical suspicion remains high.
• Monitoring: LFTs if jaundice or upper quadrant discomfort is present.

Imaging

• Recommended: Abdominal ultrasound if splenic rupture is suspected (sudden LUQ pain, tachycardia, hypotension).

Management

Acute Management

• Immediate: Supportive care, hydration, and airway assessment.
• Emergency: If airway obstruction (due to lymphoid hyperplasia) is suspected, IV corticosteroids (e.g., dexamethasone 10 mg) are indicated.

Chronic Management

• Pharmacological: NSAIDs/Acetaminophen for fever/pain. Avoid antibiotics unless streptococcal coinfection is proven.
• Non-pharmacological: Activity restriction (avoid contact sports for at least 3–4 weeks to prevent splenic rupture).
• Monitoring: Frequent follow-up until resolution of splenomegaly and normalization of LFTs.

Complications

• Common: Secondary bacterial pharyngitis, prolonged fatigue.
• Serious: Splenic rupture (occurs within the first 3 weeks), airway obstruction, autoimmune hemolytic anemia, thrombocytopenia, hemophagocytic lymphohistiocytosis (HLH).

Prognosis

• Factors: Severity of immune response and underlying health status.
• Survival: Excellent; mortality is very low and usually related to rare complications (rupture, airway, neurological).
• Quality of Life: Fatigue can persist for weeks to months (Post-viral fatigue syndrome).

Special Populations

• Pediatric: Often milder, frequently misdiagnosed as routine upper respiratory infection.
• Geriatric: May present with "fever of unknown origin"; liver involvement is more common.
• Pregnancy: Generally not teratogenic; routine monitoring for maternal complications such as anemia or thrombocytopenia.

Clinical Pearls

• Diagnostic: The classic triad (fever, pharyngitis, lymphadenopathy) is present in only 50% of patients.
• Treatment: Avoid amoxicillin/ampicillin in patients with suspected IM, as it causes a characteristic morbilliform rash in up to 90% of cases.
• Pitfalls: Don't mistake streptococcal pharyngitis for IM; test for strep if high clinical suspicion, but do not rely on antibiotics blindly if the Monospot is positive.

Key References

• Guidelines: CDC/IDSA Clinical Practice Guidelines on Viral Respiratory Infections.
• Studies: Ebell MH. Epstein-Barr virus infectious mononucleosis. Am Fam Physician. 2004.
• Reviews: Dunmire SK, et al. Infectious Mononucleosis. Curr Top Microbiol Immunol. 2015.